Effect and Mechanism of Galacto-oligosaccharides on Constipation in Mice

PAN Ya; SHEN Fei; CHEN Ming; FENG Fengqin

doi:10.13386/j.issn1002-0306.2024060073

Turn off MathJax

Article Contents

Abstract

References

PAN Ya, SHEN Fei, CHEN Ming, et al. Effect and Mechanism of Galacto-oligosaccharides on Constipation in Mice[J]. Science and Technology of Food Industry, 2025, 46(9): 1−11. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024060073.

Citation:

PDF (3244 KB)

Effect and Mechanism of Galacto-oligosaccharides on Constipation in Mice

1.
College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310000, China
2.
Hangzhou Kangyuan Food Science & Technology Co., Ltd., Hangzhou 310000, China

More Information

Received Date: June 06, 2024
Available Online: March 02, 2025

Graphical Abstract

Abstract

Abstract

Objective: To investigate the laxative effect and mechanism of galacto-oligosaccharides (GOS) on loperamide (Lop)-induced constipation in mice, which provides novel insights into the treatment of constipation. Methods: Thirty-six male BALB/C mice were randomly divided into three groups, including the blank group, the model group, and the GOS group. The growth status, defecation situation and small intestine transit rate of each group were measured. Subsequently, the morphological changes of the colon tissue were observed using HE staining. The mRNA expression levels of aquaporins, mucins, and tight junction proteins in the colon were quantified by real-time fluorescent quantitative polymerase chain reaction. The fecal intestinal microbiota composition was characterized via 16S rRNA gene sequencing, while the concentration of short-chain fatty acids was determined through gas chromatography. Results: Compared to the model group, the GOS group showed a significant increase in body weight gain (P<0.05), a notable reduction in the time of the first black stool (P<0.05), and a highly significant elevation in the number of fecal pellets and their moisture content within 5 hours (P<0.05). At the same time, the damage of the colonic tissue was alleviated. The mRNA expressions of AQP-4 and AQP-8 in the colon tissue were reduced by 69.30% and 56.38%, while the mRNA expressions of Muc-2, Muc-3, and Zo-1 were increased by 74.94%, 61.61% and 73.49%, respectively. All these variations were statistically significant (P<0.05). Meanwhile, there was a remarkable increase in the abundance of beneficial bacteria such as Lactobacillus and norank_f_Muribaculaceae in fecal samples. In the end, an obvious rise in the levels of propionic and butyric acids was observed significantly (P<0.05). Conclusion: GOS exhibits a significant effect on alleviating constipation by repairing intestinal barrier dysfunction, regulating intestinal water metabolism, and modulating the composition of gut microbiota.
- galacto-oligosaccharides,
- loperamide,
- constipation,
- gut microbiota,
- intestinal barrier

FullText(HTML)

References (65)

References

[1]	HANSON B, SIDDIQUE S M, SCARLETT Y, et al. American gastroenterological association institute technical review on the medical management of opioid-induced constipation[J]. Gastroenterology,2019,156(1):229−253. doi: 10.1053/j.gastro.2018.08.018
[2]	BHARUCHA A E, LACY B E. Mechanisms, evaluation, and management of chronic constipation[J]. Gastroenterology,2020,158(5):1232−1249. doi: 10.1053/j.gastro.2019.12.034
[3]	CAMILLERI M, FORD A C, MAWE G M, et al. Chronic constipation[J]. Nature Reviews Disease Primers,2017,3(1):17095. doi: 10.1038/nrdp.2017.95
[4]	HEIDELBAUGH J J, STELWAGON M, MILLER S A, et al. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation:Us survey assessing symptoms, care seeking, and disease burden[J]. Official Journal of the American College of Gastroenterology,2015,110(4):580−587. doi: 10.1038/ajg.2015.67
[5]	GUÉRIN A, MODY R, FOK B, et al. Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation[J]. Alimentary Pharmacology & Therapeutics,2014,40(1):83−92.
[6]	PEERY A F, CROCKETT S D, MURPHY C C, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states:Update 2018[J]. Gastroenterology,2019,156(1):254−272. doi: 10.1053/j.gastro.2018.08.063
[7]	PARK A R, OH D K. Galacto-oligosaccharide production using microbial β-galactosidase:Current state and perspectives[J]. Applied Microbiology and Biotechnology,2010,85(5):1279−1286. doi: 10.1007/s00253-009-2356-2
[8]	XU T, SUN R, ZHANG Y, et al. Recent research and application prospect of functional oligosaccharides on intestinal disease treatment[J]. Molecules,2022,27(21):7622. doi: 10.3390/molecules27217622
[9]	LI P H, LU W C, CHAN Y J, et al. Feasibility of using seaweed (Gracilaria coronopifolia) synbiotic as a bioactive material for intestinal health[J]. Foods,2019,8(12):623. doi: 10.3390/foods8120623
[10]	QAMAR T R, IQBAL S, SYED F, et al. Impact of novel prebiotic galacto-oligosaccharides on various biomarkers of colorectal cancer in wister rats[J]. International Journal of Molecular Sciences,2017,18(9):1785. doi: 10.3390/ijms18091785
[11]	WEAVER C M, MARTIN B R, NAKATSU C H, et al. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation[J]. Journal of Agricultural and Food Chemistry,2011,59(12):6501−6510. doi: 10.1021/jf2009777
[12]	SCHOEMAKER M H, HAGEMAN J H J, TEN HAAF D, et al. Prebiotic galacto-oligosaccharides impact stool frequency and fecal microbiota in self-reported constipated adults:A randomized clinical trial[J]. Nutrients,2022,14(2):309. doi: 10.3390/nu14020309
[13]	TEURI U, KORPELA R. Galacto-oligosaccharides relieve constipation in elderly people[J]. Annals of Nutrition & Metabolism,1998,42(6):319−327.
[14]	SIERRA C, BERNAL M J, BLASCO J, et al. Prebiotic effect during the first year of life in healthy infants fed formula containing gos as the only prebiotic:A multicentre, randomised, double-blind and placebo-controlled trial[J]. European Journal of Nutrition,2015,54(1):89−99. doi: 10.1007/s00394-014-0689-9
[15]	WANG L, HU L, YAN S, et al. Effects of different oligosaccharides at various dosages on the composition of gut microbiota and short-chain fatty acids in mice with constipation[J]. Food & Function,2017,8(5):1966−1978.
[16]	GAO X, HU Y, TAO Y, et al. Cymbopogon citratus (DC.) stapf aqueous extract ameliorates loperamide-induced constipation in mice by promoting gastrointestinal motility and regulating the gut microbiota[J]. Frontiers in Microbiology,2022,13:1017804. doi: 10.3389/fmicb.2022.1017804
[17]	WANG L, CHAI M, WANG J, et al. Bifidobacterium longum relieves constipation by regulating the intestinal barrier of mice[J]. Food & Function,2022,13(9):5037−5049.
[18]	WANG G, WANG H, JIN Y, et al. Galactooligosaccharides as a protective agent for intestinal barrier and its regulatory functions for intestinal microbiota[J]. Food Research International,2022,155:111003. doi: 10.1016/j.foodres.2022.111003
[19]	CAI W F, LIN S X, MA P Y, et al. Semen pruni oil attenuates loperamide-induced constipation in mice by regulating neurotransmitters, oxidative stress and inflammatory response[J]. Journal of Functional Foods,2023,107:105676. doi: 10.1016/j.jff.2023.105676
[20]	HUANG H, WANG Y T, DING X F, et al. Hemp seeds attenuate loperamide-induced constipation in mice[J]. Frontiers in Microbiology,2024,15:1353105.
[21]	王倩男, 杨雯, 薛婷芳, 等. 人参肽对小鼠的润肠通便效果[J]. 食品工业科技,2025,46(2):317−323. [WANG Q N, YANG W, XUE T F, et al. Study on the effect of ginseng peptide on laxative in mice[J]. Science and Technology of Food Industry,2025,46(2):317−323.] WANG Q N, YANG W, XUE T F, et al. Study on the effect of ginseng peptide on laxative in mice[J]. Science and Technology of Food Industry, 2025, 46（2）: 317−323.
[22]	钟浩. 植物乳杆菌缓解高脂膳食诱导小鼠胰岛素抵抗的作用及其机理探究[D]. 杭州:浙江大学, 2023. [ZHONG H. Exploring the effects and potential mechanisms of Lactobacillus plantarum in attenuating high-fat diet induced insulin resistance in mice[D]. Hangzhou:Zhejiang University, 2023.] ZHONG H. Exploring the effects and potential mechanisms of Lactobacillus plantarum in attenuating high-fat diet induced insulin resistance in mice[D]. Hangzhou: Zhejiang University, 2023.
[23]	SHI Y, CHEN F, WANG Z, et al. Effect and mechanism of functional compound fruit drink on gut microbiota in constipation mice[J]. Food Chemisty,2023,401:134210. doi: 10.1016/j.foodchem.2022.134210
[24]	ZHANG J, FENG F, ZHAO M. Glycerol monocaprylate modulates gut microbiota and increases short-chain fatty acids production without adverse effects on metabolism and inflammation[J]. Nutrients,2021,13(5):1427. doi: 10.3390/nu13051427
[25]	ZHAO Y, ZHANG C, YU L, et al. Strain-specific effect of Limosilactobacillus fermentum with distinct genetic lineages on loperamide-induced constipation in mice:Attributing effects to certain genes[J]. Food & Function,2022,13(24):12742−12754.
[26]	韩伟林, 冼俊思, 李容娣, 等. 桑叶粉的润肠通便作用[J]. 蚕业科学,2023,49(3):277−282. [HAN W L, XIAN J S, LI R D, et al. Study on the laxative function of mulberry leaf powder[J]. Acta Sericologica Sinica,2023,49(3):277−282.] HAN W L, XIAN J S, LI R D, et al. Study on the laxative function of mulberry leaf powder[J]. Acta Sericologica Sinica, 2023, 49（3）: 277−282.
[27]	姚一博, 王迪, 王钱陶, 等. 盐酸洛哌丁胺诱导的小鼠慢传输型便秘模型的实验研究[J]. 中国实验动物学报,2020,28(3):370−375. [YAO Y B, WANG D, WANG Q T, et al. Experimental study of slow transit constipation induced by loperamide hydrochloride in mice[J]. Acta Laboratorium Animalis Scientia Sinica,2020,28(3):370−375.] doi: 10.3969/j.issn.1005-4847.2020.03.012 YAO Y B, WANG D, WANG Q T, et al. Experimental study of slow transit constipation induced by loperamide hydrochloride in mice[J]. Acta Laboratorium Animalis Scientia Sinica, 2020, 28（3）: 370−375. doi: 10.3969/j.issn.1005-4847.2020.03.012
[28]	ZHOU X, CHEN Y, MA X, et al. Efficacy of Bacillus coagulans bc01 on loperamide hydrochloride-induced constipation model in kunming mice[J]. Frontiers In Nutrition,2022,9:964257. doi: 10.3389/fnut.2022.964257
[29]	QIU B, ZHU L, ZHANG S, et al. Prevention of loperamide-induced constipation in mice and alteration of 5-hydroxytryotamine signaling by Ligilactobacillus salivarius Li01[J]. Nutrients, 2022, 14(19): 4083.
[30]	KWON J I, PARK Y, NOH D O, et al. Complex-oligosaccharide composed of galacto-oligosaccharide and lactulose ameliorates loperamide-induced constipation in rats[J]. Food Science and Biotechnology,2018,27(3):781−788. doi: 10.1007/s10068-017-0300-2
[31]	SHI J, XIE Q, YUE Y, et al. Gut microbiota modulation and anti-inflammatory properties of mixed Lactobacilli in dextran sodium sulfate-induced colitis in mice[J]. Food & Function,2021,12(11):5130−5143.
[32]	CUI L, HUA Y, ZOU S, et al. Combination of fenchone and sodium hyaluronate ameliorated constipation-predominant irritable bowel syndrome and underlying mechanisms[J]. Chemical Biology & Drug Design,2024,103(1):e14397.
[33]	ZHANG X, YANG H, ZHENG J, et al. Chitosan oligosaccharides attenuate loperamide-induced constipation through regulation of gut microbiota in mice[J]. Carbohydrate Polymers,2021,253:117218. doi: 10.1016/j.carbpol.2020.117218
[34]	SU Y, ZHU R, PANG C, et al. Laxative effect of Wenyang Yiqi decoction on loperamide-induced astriction model mice[J]. Annals of Translational Medicine,2023,11(4):170. doi: 10.21037/atm-23-6
[35]	SALVO ROMERO E, ALONSO COTONER C, PARDO CAMACHO C, et al. The intestinal barrier function and its involvement in digestive disease[J]. Revista Espanola de Enfermedades Digestivas,2015,107(11):686−696.
[36]	AGRE P. The aquaporin water channels[J]. Proceedings of the American Thoracic Society,2006,3(1):5−13. doi: 10.1513/pats.200510-109JH
[37]	DENG Y, LI M, MEI L, et al. Manipulation of intestinal dysbiosis by a bacterial mixture ameliorates loperamide-induced constipation in rats[J]. Beneficial Microbes,2018,9(3):453−464. doi: 10.3920/BM2017.0062
[38]	CAO Y, HE Y, WEI C, et al. Aquaporins alteration profiles revealed different actions of senna, sennosides, and sennoside a in diarrhea-rats [J]. International Journal of Molecular Sciences, 2018, 19(10): 3210.
[39]	HU T G, WEN P, FU H Z, et al. Protective effect of mulberry (Morus atropurpurea) fruit against diphenoxylate-induced constipation in mice through the modulation of gut microbiota[J]. Food & Function,2019,10(3):1513−1528.
[40]	HUANG J, LI S, WANG Q, et al. Pediococcus pentosaceus b49 from human colostrum ameliorates constipation in mice[J]. Food & Function,2020,11(6):5607−5620.
[41]	SUN Y, YAN C, JIN S, et al. Curative effect and mechanism of Guiren Runchang granules on morphine-induced slow transit constipation in mice[J]. Evidence-based Complementary and Alternative Medicine,2020,2020:5493192. doi: 10.1155/2020/5493192
[42]	LU Y, YU Z, ZHANG Z, et al. Bifidobacterium animalis f1-7 in combination with konjac glucomannan improves constipation in mice via humoral transport[J]. Food & Function,2021,12(2):791−801.
[43]	JOHANSSON M E V, SJÖVALL H, HANSSON G C. The gastrointestinal mucus system in health and disease[J]. Nature Reviews Gastroenterology & Hepatology,2013,10(6):352−361.
[44]	LI R, XU S, LI B, et al. Gut indigenous Ruminococcus gnavus alleviates constipation and stress-related behaviors in mice with loperamide-induced constipation[J]. Food & Function,2023,14(12):5702−5715.
[45]	QIAO H, ZHAO T, YIN J, et al. Structural characteristics of inulin and microcrystalline cellulose and their effect on ameliorating colitis and altering colonic microbiota in dextran sodium sulfate-induced colitic mice[J]. ACS Omega,2022,7(13):10921−10932. doi: 10.1021/acsomega.1c06552
[46]	VRIESMAN M H, KOPPEN I J N, CAMILLERI M, et al. Management of functional constipation in children and adults[J]. Nature Reviews Gastroenterology & Hepatology,2020,17(1):21−39.
[47]	GUO M, YAO J, YANG F, et al. The composition of intestinal microbiota and its association with functional constipation of the elderly patients[J]. Future Microbiology,2020,15(3):163−175. doi: 10.2217/fmb-2019-0283
[48]	KIM M C, LEE S, PARK J K, et al. Effects of id-hws1000 on the perception of bowel activity and microbiome in subjects with functional constipation:A randomized, double-blind placebo-controlled study[J]. Journal of Medicinal Food,2021,24(8):883−893. doi: 10.1089/jmf.2020.4746
[49]	LAGKOUVARDOS I, LESKER T R, HITCH T C A, et al. Sequence and cultivation study of muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family[J]. Microbiome,2019,7(1):28. doi: 10.1186/s40168-019-0637-2
[50]	HU Y, GAO X, ZHAO Y, et al. Flavonoids in Amomum tsaoko Crevost et lemarie ameliorate loperamide-induced constipation in mice by regulating gut microbiota and related metabolites [J]. International Journal of Molecular Sciences, 2023, 24(8): 7191.
[51]	DIMIDI E, CHRISTODOULIDES S, SCOTT S M, et al. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation[J]. Advances in Nutrition,2017,8(3):484−494. doi: 10.3945/an.116.014407
[52]	LIU G, HUANG Y, ZHAI L. Impact of nutritional and environmental factors on inflammation, oxidative stress, and the microbiome[J]. BioMed Research International,2018,2018:5606845.
[53]	HU S, LI S, LIU Y, et al. Aged ripe pu-erh tea reduced oxidative stress-mediated inflammation in dextran sulfate sodium-induced colitis mice by regulating intestinal microbes[J]. Journal of Agricultural and Food Chemistry,2021,69(36):10592−10605. doi: 10.1021/acs.jafc.1c04032
[54]	WANG L, WANG R, WEI G Y, et al. Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism[J]. Pharmacological Research,2021,163:105232. doi: 10.1016/j.phrs.2020.105232
[55]	ZAGATO E, POZZI C, BERTOCCHI A, et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth[J]. Nature Microbiology,2020,5(3):511−524. doi: 10.1038/s41564-019-0649-5
[56]	WATSON D, O'CONNELL MOTHERWAY M, SCHOTERMAN M H, et al. Selective carbohydrate utilization by lactobacilli and bifidobacteria[J]. Journal of Applied Microbiology,2013,114(4):1132−1146. doi: 10.1111/jam.12105
[57]	ARNOLD J W, ROACH J, FABELA S, et al. The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut[J]. Microbiome,2021,9(1):31. doi: 10.1186/s40168-020-00980-0
[58]	BEN X M, ZHOU X Y, ZHAO W H, et al. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants[J]. Chinese Medical Journal,2004,117(6):927−931.
[59]	LIN Q, LIU M, ERHUNMWUNSEE F, et al. Chinese patent medicine shouhui tongbian capsule attenuated loperamide-induced constipation through modulating the gut microbiota in rat[J]. Journal of Ethnopharmacology,2022,298:115575. doi: 10.1016/j.jep.2022.115575
[60]	HOSSEINI E, GROOTAERT C, VERSTRAETE W, et al. Propionate as a health-promoting microbial metabolite in the human gut[J]. Nutrition Reviews,2011,69(5):245−258. doi: 10.1111/j.1753-4887.2011.00388.x
[61]	JIANG H, DONG J, JIANG S, et al. Effect of Durio zibethinus rind polysaccharide on functional constipation and intestinal microbiota in rats[J]. Food Research International,2020,136:109316. doi: 10.1016/j.foodres.2020.109316
[62]	SORET R, CHEVALIER J, DE COPPET P, et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats[J]. Gastroenterology,2010,138(5):1772−1782. doi: 10.1053/j.gastro.2010.01.053
[63]	PROCHÁZKOVÁ N, FALONY G, DRAGSTED L O, et al. Advancing human gut microbiota research by considering gut transit time[J]. Gut,2023,72(1):180−191. doi: 10.1136/gutjnl-2022-328166
[64]	ZHANG C, WANG L, LIU X, et al. The different ways multi-strain probiotics with different ratios of bifidobacterium and lactobacillus relieve constipation induced by loperamide in mice[J]. Nutrients,2023,15(19):4230. doi: 10.3390/nu15194230
[65]	ZHANG Q, ZHONG D, SUN R, et al. Prevention of loperamide induced constipation in mice by kgm and the mechanisms of different gastrointestinal tract microbiota regulation[J]. Carbohydrate Polymers,2021,256:117418. doi: 10.1016/j.carbpol.2020.117418